HC Wainwright reissued their buy rating on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note released on Monday, Zacks.com reports.
A number of other research firms have also recently weighed in on RKDA. National Securities restated a buy rating and issued a $15.00 price target on shares of Arcadia Biosciences in a research note on Thursday, May 9th. ValuEngine upgraded Arcadia Biosciences from a sell rating to a hold rating in a research note on Thursday, August 1st.
RKDA opened at $8.14 on Monday. Arcadia Biosciences has a 1-year low of $1.82 and a 1-year high of $10.40. The stock’s fifty day simple moving average is $3.20 and its 200 day simple moving average is $5.03. The company has a current ratio of 6.26, a quick ratio of 6.19 and a debt-to-equity ratio of 2.80. The stock has a market cap of $38.17 million, a PE ratio of -1.52 and a beta of -2.01.
A number of institutional investors and hedge funds have recently bought and sold shares of RKDA. Morgan Stanley raised its stake in Arcadia Biosciences by 162,800.0% in the 2nd quarter. Morgan Stanley now owns 81,450 shares of the basic materials company’s stock valued at $250,000 after acquiring an additional 81,400 shares during the period. Vanguard Group Inc. increased its position in Arcadia Biosciences by 47.1% during the 2nd quarter. Vanguard Group Inc. now owns 117,059 shares of the basic materials company’s stock worth $359,000 after buying an additional 37,472 shares during the period. Cambridge Investment Research Advisors Inc. bought a new position in Arcadia Biosciences during the 2nd quarter worth $34,000. Finally, Citadel Advisors LLC bought a new position in Arcadia Biosciences during the 2nd quarter worth $32,000. Institutional investors and hedge funds own 3.11% of the company’s stock.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.
Recommended Story: Operating Income
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.